Equities

Boundless Bio Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BOLD:NSQ

Boundless Bio Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.15
  • Today's Change-0.015 / -1.29%
  • Shares traded105.28k
  • 1 Year change-48.42%
  • Beta--
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Forecasts data is unavailable for this security.

Consensus recommendation

  • 20-Feb-25
  • 20-Nov-25
  • 18-Dec-25
  • 15-Jan-26
  • 05-Feb-26
Select bar for recommendation details.
Recommendations05-Feb-26
Buy0
Outperform0
Hold2
Sell0
Strong Sell0

Share price forecast in USD

The one analyst offering a 12 month price target expects Boundless Bio Inc share price to rise to 3.00 in the next year from the last price of 1.16.
High158.6%3.00
Med158.6%3.00
Low158.6%3.00

Earnings history & estimates in USD

On Nov 05, 2025, Boundless Bio Inc reported 3rd quarter 2025 losses of -0.62 per share.
The next earnings announcement is expected on Mar 23, 2026.
Average growth rate+4.22%
Boundless Bio Inc reported annual 2024 losses of -3.85 per share on Mar 27, 2025.
More ▼

Revenue history & estimates in USD

Boundless Bio Inc did not report revenues for the 3rd quarter 2025. However, during the 3rd quarter of the prior year the company reported revenues of 0.00.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.